Volume 2, Issue 3, Fall 2025

View Volume 2, Issue 3, Fall 2025

Treatment of dMMR Metastatic Colorectal Cancer in 2025
First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer
Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks
Current Issues in the Management of Sporadic Non-clear Cell Renal Cell Carcinoma (Non-ccRCC)

Published: 2025-11-05

Full Issue

Articles

Treatment of dMMR Metastatic Colorectal Cancer in 2025

Renata D’Alpino Peixoto, MD, PhD, Thiago Miranda do Amaral, MD

6–11
- PDF (en)
- PDF (fr)
First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer

Arwa Ahmed Abdelrahim, MD, Rachel Goodwin, MD

12–20
- PDF (en)
- PDF (fr)
Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks

Yunting Liu, Steven Shen, Manav Shukla, Janet Malowany, Shaheed Hakim, Zared Aziz, David N. Parente, Victoria Cheung, Suneil Khanna, Yoo-Joung Ko, Wondwossen Kidanewold, Michael A. Ko, Kelsie L. Thu, Ju-Yoon Yoon

22–28
- PDF (en)
- PDF (fr)
Current Issues in the Management of Sporadic Non-clear Cell Renal Cell Carcinoma (Non-ccRCC)

Mariam Jafri, MBChB (Hons), MRCP(UK), BMedSc, MSc, Ph.D

29–34
- PDF (en)
- PDF (fr)